Nepafenac
Back to searchMolecule Structure
Scientific Name
Nepafenac
Description of the Drug
Nepafenac is an ophthalmic NSAID used for the symptomatic treatment of pain and inflammation associated with cataract surgery.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06802
http://www.drugbank.ca/drugs/DB06802
Brand Name(s)
Ilevro, Nepafenac, Nevanac
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL93835 | ||
| PharmGKB | PA165958407 | ||
| Human Metabolome Database | HMDB0015678 | ||
| DrugBank | DB06802 | ||
| PubChem: Thomson Pharma | 14774447 | ||
| PubChem | 151075 | ||
| LINCS | LSM-45729 | ||
| Nikkaji | J332.082K | ||
| BindingDB | 50228731 | ||
| EPA CompTox Dashboard | DTXSID0048638 | ||
| DrugCentral | 1899 | ||
| ChemicalBook | CB01116872 | CB72646395 | |
| Guide to Pharmacology | 7564 | ||
| rxnorm | ILEVRO | NEPAFENAC | NEVANAC |
| ChEBI | 75922 | ||
| ZINC | ZINC000005162311 |
